Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Jordan

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Best Practice & Research. Clinical Haematology|December 4, 2012
How close are we to targeting the leukemia stem cell?Shanshan Pei, Craig T Jordan
Blood Reviews|January 11, 2011
Leukemia stem cells in 2010: current understanding and future directionsMichael W Becker, Craig T Jordan
Oncogene|September 21, 2004
Mechanisms controlling pathogenesis and survival of leukemic stem cellsCraig T Jordan, Monica L Guzman
Cell Stem Cell|September 3, 2011
Leukemia stemness signatures step toward the clinicMichael W Becker, Craig T Jordan
Current Opinion in Hematology|January 18, 2019
Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?Daniel A Pollyea, Craig T Jordan
Methods in Molecular Medicine|March 26, 2011
Isolation and characterization of primitive hematopoietic cells based on their position in the cell cycleEdward F Srour, Craig T Jordan
Blood|February 5, 2017
Therapeutic targeting of acute myeloid leukemia stem cellsDaniel A Pollyea, Craig T Jordan
Cancer Control : Journal of the Moffitt Cancer Center|March 17, 2004
Considerations for targeting malignant stem cells in leukemiaMonica L Guzman, Craig T Jordan
Science (New York, N.Y.)|June 27, 2009
The increasing complexity of the cancer stem cell paradigmJeffrey M Rosen, Craig T Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Leukemia stem cells and microenvironment: biology and therapeutic targetingMarina Y Konopleva, Craig T Jordan
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Best Practice & Research. Clinical Haematology|December 4, 2012
How close are we to targeting the leukemia stem cell?Shanshan Pei, Craig T Jordan
Blood Reviews|January 11, 2011
Leukemia stem cells in 2010: current understanding and future directionsMichael W Becker, Craig T Jordan
Oncogene|September 21, 2004
Mechanisms controlling pathogenesis and survival of leukemic stem cellsCraig T Jordan, Monica L Guzman
Cell Stem Cell|September 3, 2011
Leukemia stemness signatures step toward the clinicMichael W Becker, Craig T Jordan
Current Opinion in Hematology|January 18, 2019
Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?Daniel A Pollyea, Craig T Jordan
Methods in Molecular Medicine|March 26, 2011
Isolation and characterization of primitive hematopoietic cells based on their position in the cell cycleEdward F Srour, Craig T Jordan
Blood|February 5, 2017
Therapeutic targeting of acute myeloid leukemia stem cellsDaniel A Pollyea, Craig T Jordan
Cancer Control : Journal of the Moffitt Cancer Center|March 17, 2004
Considerations for targeting malignant stem cells in leukemiaMonica L Guzman, Craig T Jordan
Science (New York, N.Y.)|June 27, 2009
The increasing complexity of the cancer stem cell paradigmJeffrey M Rosen, Craig T Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Leukemia stem cells and microenvironment: biology and therapeutic targetingMarina Y Konopleva, Craig T Jordan
Pageof 17